amgen bone news - Search News

Amgen, bone mineral density

YAHOO!Finance · 6h

Amgen speaks out about bone density concerns with obesity drug

Amgen’s stock fell 7% after an analyst posted a note on MariTide’s influence on bone density which was noticed in a data spreadsheet.

Amgen dismisses bone density concerns related to its weight-loss drug

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone mineral density, a day after data from an early-stage study dragged its stock 7% lower.

Amgen defends obesity drug amid bone concerns

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and has asked the journal to issue a correction and add in the finalized data.

1d

What’s Happening With Amgen Stock?

In this photo illustration, Amgen logo is displayed on a smartphone with a S&P ... [+] index website background. (Photo ...

2d

Amgen slips as Cantor cites safety concerns linked to obesity candidate

Amgen (AMGN) stock falls as Cantor Fitzgerald raises safety concerns over bone mineral density loss linked to obesity ...

1d

Amgen Says No Link Between MariTide And Changes In Bone Mineral Density

Wednesday said there is no association between administration of experimental weight loss drug MariTide and changes ...

1d

Signal Says Pharma Stock Selloff Should Be Over

Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.

Hosted on MSN1d

Amgen dismisses bone density concerns related to its new weight-loss drug

(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results